NASDAQ: ICCCImmucell Corp Stock Ownership - Who owns Immucell?
Insider buying vs selling
Have Immucell Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bryan K. Gathagan | Director | 2025-06-12 | 1,000 | $6.32 | $6.32kBuy |
| Gloria F. Basse | Director | 2025-06-11 | 3,530 | $4.81 | $16.98kBuy |
| David Scott Tomsche | Director | 2024-08-28 | 2,186 | $3.55 | $7.76kBuy |
| David Scott Tomsche | Director | 2024-08-23 | 6,005 | $3.55 | $21.32kBuy |
| David Scott Tomsche | Director | 2024-08-22 | 10,000 | $3.55 | $35.50kBuy |
| David Scott Tomsche | Director | 2024-08-19 | 3,172 | $3.67 | $11.64kBuy |
| David Scott Tomsche | Director | 2024-08-16 | 4,811 | $3.72 | $17.88kBuy |
| David Scott Tomsche | Director | 2024-08-15 | 2,017 | $3.57 | $7.19kBuy |
ICCC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ICCC insiders and whales buy or sell their stock.
ICCC Shareholders
What type of owners hold Immucell Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Norman H. Pessin | 7.19% | 650,000 | $4.20M | Insider |
| Jonathan E. Rothschild | 5.69% | 514,003 | $3.32M | Insider |
| David Scott Tomsche | 2.62% | 236,883 | $1.53M | Insider |
| Vanguard Group Inc | 2.50% | 225,595 | $1.46M | Institution |
| Michael F. Brigham | 2.27% | 204,752 | $1.32M | Insider |
| Joseph H. Crabb | 1.58% | 142,845 | $922.78k | Insider |
| Renaissance Technologies LLC | 1.48% | 133,989 | $865.57k | Institution |
| Cresset Asset Management LLC | 1.46% | 132,001 | $852.73k | Institution |
| Dauntless Investment Group LLC | 1.45% | 131,195 | $847.52k | Institution |
| Bleichroeder LP | 1.12% | 101,594 | $656.30k | Institution |
ICCC vs Biotech Stocks
Immucell Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.